Mayfair Advisory Group’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $906K | Buy |
1,449
+1
| +0.1% | +$625 | 0.43% | 49 |
|
|
2025
Q1 | $1.2M | Sell |
1,448
-85
| -6% | -$70.2K | 0.69% | 33 |
|
|
2024
Q4 | $1.18M | Buy |
1,533
+64
| +4% | +$49.4K | 0.7% | 31 |
|
|
2024
Q3 | $1.3M | Buy |
1,469
+6
| +0.4% | +$5.32K | 0.82% | 26 |
|
|
2024
Q2 | $1.39M | Sell |
1,463
-26
| -2% | -$24.7K | 0.94% | 25 |
|
|
2024
Q1 | $1.16M | Buy |
1,489
+80
| +6% | +$62.2K | 0.84% | 27 |
|
|
2023
Q4 | $834K | Buy |
1,409
+12
| +0.9% | +$7.11K | 0.71% | 31 |
|
|
2023
Q3 | $809K | Hold |
1,397
| – | – | 0.78% | 29 |
|
|
2023
Q2 | $632K | Hold |
1,397
| – | – | 0.63% | 39 |
|
|
2023
Q1 | $523K | Sell |
1,397
-55
| -4% | -$20.6K | 0.57% | 43 |
|
|
2022
Q4 | $508K | Buy |
1,452
+55
| +4% | +$19.2K | 0.65% | 40 |
|
|
2022
Q3 | $449K | Sell |
1,397
-550
| -28% | -$177K | 0.63% | 42 |
|
|
2022
Q2 | $642K | Hold |
1,947
| – | – | 0.85% | 31 |
|
|
2022
Q1 | $570K | Buy |
1,947
+158
| +9% | +$46.3K | 0.73% | 35 |
|
|
2021
Q4 | $466K | Buy |
1,789
+35
| +2% | +$9.12K | 0.62% | 38 |
|
|
2021
Q3 | $394K | Hold |
1,754
| – | – | 0.6% | 44 |
|
|
2021
Q2 | $403K | Buy |
1,754
+34
| +2% | +$7.81K | 0.64% | 41 |
|
|
2021
Q1 | $319K | Hold |
1,720
| – | – | 0.57% | 45 |
|
|
2020
Q4 | $290K | Buy |
1,720
+14
| +0.8% | +$2.36K | 0.57% | 48 |
|
|
2020
Q3 | $253K | Hold |
1,706
| – | – | 0.65% | 41 |
|
|
2020
Q2 | $280K | Buy |
+1,706
| New | +$280K | 0.9% | 25 |
|